Home  >  Products  >  IPO8 (importin 8 ) Blocking Peptide (the C terminal of IPO8)(100ug)
IPO8 (importin 8 ) Blocking Peptide (the C terminal of IPO8)(100ug)

IPO8 (importin 8 ) Blocking Peptide (the C terminal of IPO8)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-IPO8 Antibody (ARP65771_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP65771
Size: 100ug
Weight: 96kDa
Gene: 10526
Format: Lyophilized powder
Target: The importin-alpha/beta complex and the GTPase Ran mediate nuclear import of proteins with a classical nuclear localization signal. The protein encoded by this gene is a member of a class of approximately 20 potential Ran targets that share a sequence motif related to the Ran-binding site of importin-beta. This protein binds to the nuclear pore complex and, along with RanGTP and RANBP1, inhibits the GAP stimulation of the Ran GTPase. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Alternative names: FLJ26580; RANBP8
See Full Product Listings >